BebenekMPudetkoMBlaszczykJ. Breast cancer incidence and mortality in Lower Silesia (Poland) between 1984 and 2003—trends and perspectives. Central European Journal of Medicine 2007;2:208–15.
2.
BrayF. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002;38:99–166.
3.
BrownHSGobleRKirschnerH.Social and environmental factors in lung cancer mortality in post-war Poland. Environ Health Perspect1995; 103:64–70.
4.
International Agency for Research on Cancer. GLOBOCAN2002 [cited 2008 Apr 1]. Available from: URL: http://www-dep.iarc.fr
5.
MederJ. Oncological issues in the field of public health. Warsaw (Poland): Postgraduate Medical Center and Oncological Center Institute; 2006.
6.
MacLennanAHWilsonDHTaylorAW. The escalating costs and prevalence of alternative medicine. Prev Med2002; 35:166–73.
AntezanaFSChollat-TraquetCMYachD.Health for all in the 21st century. World Health Stat Q1998; 51:3–6.
18.
Department of Medical Statistics, National Institute of Hygiene. Health programme for years1996 −2005 [cited 2008 Apr 1]. Available from: URL: http://www.medstat.waw.pl/nhp_p/1_p.html
19.
HendrickRESmithRARutledgeJHIIISmartCR. Benefit of screening mammography in women aged 40–49: A new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr1997; 22:87–92.
Europe Against Cancer programme of the European Community. European Code Against Cancer and Science Justification: Third version. 2003 [cited 2008 Feb 26]. Available from: URL: http://www.cancercode.org/code_01.htm
22.
ZatonskiW, editor. European cancer code. Polish edition. 3rd version. Warsaw: Oncological Center Institute; 2007.
23.
DollRPetoR.The causes of cancer; quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst1981; 66:1191–308.